Alkermes (ALKS) EBT Margin (2010 - 2026)
Alkermes (ALKS) posted quarterly EBT Margin of 0.38% for Q2 2026, down 2721.0% year-over-year from 0.01% in Q2 2025, and up 97.6% quarter-over-quarter from 15.76% in Q1 2026.
Alkermes (ALKS) EBT Margin (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported EBT Margin for 17 consecutive years, with 0.38% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBT Margin fell 2721.0% year-over-year to 0.38%; the TTM figure through Jun 2026 stood at 5.84% (down 2143.0% YoY), while the FY2025 annual figure was 19.75%, down 874.0% from the prior year.
- EBT Margin climbed to 0.38% in Q2 2026 per ALKS's latest filing, from 15.76% in the prior quarter.
- Across five years, EBT Margin topped out at 45.65% in Q2 2023 and bottomed at 2105.25% in Q3 2022.
- Historically, EBT Margin has averaged 159.44% across 5 years, with a median of 15.57% in 2023.
- Annual changes were most pronounced in 2022 — EBT Margin tumbled 209623 bps — and 2023, when it soared 212959 bps.
- Alkermes' EBT Margin stood at 37.58% in 2022, then sank by 59 bps to 15.45% in 2023, then jumped by 156 bps to 39.51% in 2024, then sank by 60 bps to 15.7% in 2025, then sank by 102 bps to 0.38% in 2026.
- Business Quant data shows ALKS's EBT Margin at 0.38% in Q2 2026, 15.76% in Q1 2026, and 15.7% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -0.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.38% |
| Mar 31, 2026 | -15.76% |
| Dec 31, 2025 | 15.70% |
| Sep 30, 2025 | 25.56% |
| Jun 30, 2025 | 26.84% |
| Mar 31, 2025 | 8.32% |
| Dec 31, 2024 | 39.51% |
| Sep 30, 2024 | 29.15% |
| Jun 30, 2024 | 29.24% |
| Mar 31, 2024 | 13.39% |
| Dec 31, 2023 | 15.45% |
| Sep 30, 2023 | 24.34% |
| Jun 30, 2023 | 45.65% |
| Mar 31, 2023 | -3.94% |
| Dec 31, 2022 | 37.58% |
| Sep 30, 2022 | -2,105.25% |
| Jun 30, 2022 | -1,039.06% |
| Mar 31, 2022 | -16.15% |
| Dec 31, 2021 | 39.22% |
| Sep 30, 2021 | -9.02% |